Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Ultrasound Enhancement with Sonazoid for Preoperative Identification and Assessment of Sentinel Lymph Nodes in Cutaneous Melanoma Patients

  • By

  • Binbin Jiang

  • Liqi Sun

  • Lu Si

  • Jiayong Liu

  • Chuanliang Cui

  • Kun Yan

  • Shanshan Yin

  • May 25, 2026

Share

  • 1

    Cutaneous malignant melanoma is a prevalent skin cancer, with sentinel lymph nodes being critical for staging and treatment planning.

  • 2

    Sentinel lymph node biopsy is the standard procedure for clinically node-negative melanoma patients, providing essential prognostic information.

  • 3

    Traditional SLN localization methods, like lymphoscintigraphy, have limitations including allergic reactions and radiation risks.

  • 4

    Sonazoid, a novel ultrasound contrast agent, enhances SLN visualization and offers advantages over traditional tracers in melanoma staging.

  • 5

    This study evaluates the feasibility and safety of Sonazoid for SLN identification, aiming to improve preoperative staging in melanoma patients.

Original Source(s)

Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma

  • by Binbin Jiang, Liqi Sun, Lu Si, Jiayong Liu, Chuanliang Cui, Kun Yan, Shanshan Yin

  • May 25, 2026

Related Content

Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments)

What Medicare Claims Tell Us About Cancer Disparities in American Indian and Alaska Native Peoples

Physician- and Practice-Level Variation in Clinical Trial Participation Among Patients With Advanced Cancer